18F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 6, 2010, Pages 1181-1188

  Keijsers, Ruth G ^a   Grutters, Jan C ^a   Van Velzen Blad, Heleen ^a   Van Den Bosch, Jules M ^a   Oyen, Wim J ^b   Verzijlbergen, Fred J ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F FDG PET; Bronchoalveolar lavage; Pulmonary sarcoidosis

Indexed keywords

CD103 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CD4 CD8 RATIO; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; LUNG HILUS; LUNG LAVAGE; LUNG PARENCHYMA; LUNG SARCOIDOSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; NEUTROPHIL; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY;

EID: 77954888580     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1376-6     Document Type: Article

References (17)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.
2. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961;2:1165-72.
3. Braun JJ, Kessler R, Constantinesco A, Imperiale A. (18) F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008;35:1537-43.
4. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47:1571-6.
5. Yamada Y, Uchida Y, Tatsumi K, Yamaguchi T, Kimura H, Kitahara H, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 1998;39:1160-6.
6. Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl 2001;32:56s-68.
7. Verstraeten A, Demedts M, Verwilghen J, van den Eeckhout A, Mariën G, Lacquet LM, et al. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest 1990;98:560-7.
8. Ziegenhagen MW, Rothe ME, Schlaak M, Müller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003;21:407-13.
9. Drent M, Jacobs JA, de Vries J, Lamers RJ, Liem IH, Wouters EF. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999;13:1338-44.
10. Heron M, Slieker WA, Zanen P, van Lochem EG, Hooijkaas H, van den Bosch JM, et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008;126:338-44.
11. Kolopp-Sarda MN, Kohler C, De March AK, Béné MC, Faure G. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Invest 2000;80:1065-9.
12. No authors listed. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
13. Kruit A, Grutters JC, Gerritsen WB, Kos S, Wodzig WK, van den Bosch JM, et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 2007;101:510-5.
14. Kauffmann H. Standaardisatie van het protocol voor bronchoalveolaire lavage in Nederland. Pulmoscript 1994;5:66-8.
15. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-34.
16. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993;104:352-61.
17. Ward K, O'Connor C, Odlum C, Fitzgerald MX. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989;44:6-12.